Printer Friendly

Browse Pharmaceutical industry topic

Management subtopic

Articles

1-300 out of 600 article(s) nextnext page
Title Author Type Date Words
Resource Misallocation Threshold for High-Tech Industrial Specialization on Technological Innovation Performance for Pharmaceutical Manufacturing. Liang, Lei; Fan, Zhiyong Report Jul 31, 2020 7989
THE PATH TO INDUSTRY 4.0 IMPLEMENTATION: Industry 4.0 is revolutionizing the way companies do business at a faster pace than any transformation in business history. Juras, Paul; Johnson, Lauren Company overview Jun 1, 2020 3177
CHPA revamps for holistic approach. Jun 1, 2020 767
AAM Issues New Game Plan to Keep Rx Supply Chain Secure. Jun 1, 2020 1132
REVIEWING REFUSAL: LETHAL INJECTION, THE FDA, AND THE COURTS. Shi, Andrew Dec 1, 2019 14674
Solving Hard Problems with AI: Dramatically Accelerating Drug Discovery Through A Unique Public-Private Partnership. Baldoni, John; Begoli, Edmon; Kusnezov, Dimitri; MacWilliams, John Oct 1, 2019 4633
CV Sciences. Company overview Jun 3, 2019 222
Curaleaf. Company overview Jun 3, 2019 217
Ascend focuses on IT insfractructure. Apr 29, 2019 536
Sera Labs: a thriving CBD company with a difference. Apr 29, 2019 820
BBB Labs crafts all-organic line of products. Mar 18, 2019 273
A MATHEMATICAL SOLUTION TO THE SINE OF MADNESS THAT IS PHARMACEUTICAL COMPULSORY LICENSING UNDER THE TRIPS AGREEMENT AND THE DOHA DECLARATION. Sperbeck, Ashley E. Jan 1, 2019 13138
Joy Organics launches CBD oil white label program. Nov 5, 2018 471
RENOVATIONS NEEDED: THE FDA'S FLOOR/CEILING FRAMEWORK, PREEMPTION, AND THE OPIOID EPIDEMIC. Abrams, Michael R. Oct 1, 2018 14351
Setting Up and Working with a Board of Directors: A Guide for Startups. Jordan, James F. Oct 1, 2018 2980
Boosting the front end's profitability is paramount. Jul 9, 2018 731
Peer-to-peer meetings keep community growing. Jul 9, 2018 645
Financial Investment Risks in Parmaceutical Industry: Analysis on Fluctuation of Stock Price. Liang, Wei; Ge, Hongxiang Report Jul 1, 2018 3470
India's Dodgy Pharmacy. Bate, Roger Essay Nov 1, 2017 15423
Glenmark Pharmaceuticals. Company overview Sep 25, 2017 299
Dr. Reddy's Laboratories. Company overview Sep 25, 2017 820
Aurobindo Pharma. Company overview Sep 25, 2017 733
Discussion on Strengthening Financial Supervision of Pharmaceutical Industry under the Background of New Medical Reform. Yang, Chunjiang; Tan, Xiuli; Yang, Yujiang; Chen, Angel Report Jul 1, 2017 2921
Shalina and Abbas Virji: Co-CEOs, Shalina Healthcare Ltd. Collins, Tom Interview Jun 1, 2017 999
"My husband, I think I'll keep him.". Toffle, Roger Report May 1, 2017 1353
GlaxoSmithKline Ups the Ante in Consumer Health Care. Feb 20, 2017 482
Bell Takes Dual Approach With Jet. Brief article Jan 30, 2017 124
Johnson & Johnson issues insulin-pump cyber-hacking warning. Nov 1, 2016 182
Dr. Reddy's fosters patient-centric innovation. Sep 26, 2016 334
Glenmark Pharmaceuticals. Company overview Sep 26, 2016 346
Carlsbad Tech. Company overview Sep 26, 2016 406
Dr. Reddy's. Company overview Sep 26, 2016 789
Sigmapharm Laboratories. Company overview Sep 26, 2016 457
Quinn Pharmaceuticals. Company overview Sep 26, 2016 428
WN builds on strength of webber naturals. Company overview Aug 8, 2016 839
Corporate governance and financial performance of BSE listed firms: evidence from Indian pharmaceutical sector. Malik, Seema Report Jul 1, 2016 5679
Moberg Pharma announces completion of tap issue of SEK85m. Brief article Jul 1, 2016 192
Business model innovation opportunities for the biopharmaceutical industry: a systematic review. Downs, James B.; Velamuri, Vivek K. Report Jul 1, 2016 27002
Moberg Pharma launches Kerasal Nail and Emtrix in Joan; Updates on market reach of products. Brief article Jun 29, 2016 250
PPMA should form Pharma Policy and Research Advocacy Council to guide Govt. for a robust, healthy Pharma industry. Jun 15, 2016 1730
Morris & Dickson stresses service. Company overview Jun 6, 2016 426
Current problems in the research and development of more effective antidepressants. Si, Tianmei; Yu, Xin Report Jun 1, 2016 4224
De-regulation of Pharma Industry and De-control of drug prices will ensure innovations and development- Farid Hassan. Apr 15, 2016 2084
Considering the future of pharmaceutical promotions in social media: comment on "Trouble spots in online direct-to-consumer prescription drug promotion: A content analysis of FDA warning letters". Carpentier, Francesca Renee Dillman Report Apr 1, 2016 2287
The BIEM verification study: experienced venture capitalists assess a biopharmaceuticals innovation expertise model. Gunn, Moira; Masterson, Nola; Lorton, Paul, Jr.; Baronet, Jacques Report Apr 1, 2016 6553
Of pens, pizzas, and pharmaceuticals. Pitts, Peter J. Report Apr 1, 2016 1168
Catalent Pharma Solutions. Company overview Mar 1, 2016 309
J+D Labs. Company overview Mar 1, 2016 349
Boiron aims to draw more shoppers to category. Feb 8, 2016 386
Biopharmaceutical startup's need of regulatory intelligence. Schueler, Julia; Ostler, Tobias Report Jan 1, 2016 4346
An impediment to personalized medicine commercialization is the lack of understanding of the value of the testing. Johnson, Anthony Report Jan 1, 2016 1271
Pharmacy careers in Pakistan: In focus industrial pharmacy. Qureshi, Abdul Majid Column Dec 27, 2015 1109
LNK strikes a balance between quality, cost. Brief article Nov 16, 2015 331
LNK International Inc. Company overview Oct 19, 2015 611
Genomma Lab USA Inc. Company overview Oct 19, 2015 579
Boiron. Company overview Oct 19, 2015 533
Recipharm commences cost and efficiency programme in Sweden. Brief article Oct 9, 2015 244
Sigmapharm Laboratories. Sep 28, 2015 389
Dr. Reddy's Laboratories. Company overview Sep 28, 2015 566
Carlsbad Technology. Company overview Sep 28, 2015 393
Unichem Pharmaceuticals. Brief article Sep 28, 2015 222
Amneal Pharmaceuticals. Company overview Sep 28, 2015 744
Upsher-Smith Laboratories. Company overview Sep 28, 2015 368
Analysis and control of issues that delay pharmaceutical projects. Rao, Nallam Sai Nandeswara; Jigeesh, Nasina Report Sep 1, 2015 7672
Boiron provides natural treatment options. Company overview Aug 24, 2015 622
Hyland's rolls out addition to children's line. Company overview Aug 24, 2015 450
Health Plus listens to needs of customers. Company overview Aug 24, 2015 628
Jakemans raises profile in U.S. market. Company overview Aug 24, 2015 632
NeilMed raises the bar in nasal care segment. Company overview Aug 24, 2015 481
H. D. Smith positions itself as an integrated provider. Company overview Jun 1, 2015 656
Creating a culture of productivity and collaborative innovation: Orion's R&D Transformation: faced with the need to improve productivity, Orion's R&D group built a new culture of productivity and collaborative innovation through incremental initiatives and a comprehensive reorganization. Thong, Robert; Lotta, Timo May 1, 2015 7464
Permanent SGR formula fix faces a payment hurdle. Twachtman, Gregory Feb 1, 2015 1143
Ranking suppliers using QFD/FAHP method. Khalaj, Fatemeh; Denavi, Hassan Dehghan; Sadeghian, Abolfazl Report Jan 15, 2015 7335
Field changes for Research Pharma. Coopman, Robert Jan 5, 2015 461
Essential drugs production in Brazil, Russia, India, China and South Africa (BRICS): opportunities and challenges. Ezziane, Zoheir Report Dec 1, 2014 5266
Boiron. Company overview Oct 20, 2014 587
LNK International Inc. Company overview Oct 20, 2014 552
Genomma Lab USA Inc. Company overview Oct 20, 2014 570
Magic Bag. Company overview Oct 20, 2014 570
Homeolab provides safe, natural relief. Aug 25, 2014 365
The art and science of compounding: where are we now, and how did we get here? Petersen, Carol Aug 1, 2014 2312
Pharmaceutical R&D productivity: the role of alliances. Kruse, Sarah; Slomiany, Mark; Bitar, Rema; Jeffers, Sarah; Hassan, Mahmud Report May 1, 2014 6081
'Complete support' given to patients. Brief article Apr 28, 2014 161
McKesson. Company overview Mar 1, 2014 538
The power of co-creation. Vermeulen, Peter Mar 1, 2014 387
Aenova. Company overview Mar 1, 2014 339
Packaging. Company overview Mar 1, 2014 423
Premium ingredient specialists. Company overview Mar 1, 2014 691
Biotropics malaysia. Company overview Mar 1, 2014 517
Capsugel[R]. Mar 1, 2014 264
JIAHERB essentials of nature. Company overview Mar 1, 2014 361
Laboratories. Company overview Mar 1, 2014 319
Vitatech nutritional sciences, Inc. Global Custom Manufacturing. Brief article Mar 1, 2014 239
ZMC-USA. Company overview Mar 1, 2014 400
Development of corn starch-neusilin UFL2 conjugate as tablet superdisintegrant: formulation and evaluation of fast disintegrating tablets. Juneja, Prateek; Kaur, Birender; Odeku, Oluwatoyin A.; Singh, Inderbir Report Jan 1, 2014 8889
To determine and examine the prospect and feasibility study of anti-cancer drugs for local production in Bangladesh. Azad, A.K.; Islam, Aminul Nov 1, 2013 4573
Business is not about making money but doing something good-Farid Hassan. Oct 31, 2013 1533
Assessing the history and value of human genome sciences. McNamee, Laura M.; Ledley, Fred D. Oct 1, 2013 4494
Integrated outsourcing transforms and increases R&D productivity. Levy, Henry Oct 1, 2013 2520
Competition regulation and recombinant drugs in India. Bhardwaj, Ravikant; Manchikanti, Padmavati; Raju, K.D. Oct 1, 2013 8505
Heritage Pharmaceuticals. Company overview Sep 30, 2013 430
Dr. Reddy's. Company overview Sep 30, 2013 337
Hyland's cuts through 'clutter' in market. Company overview Aug 19, 2013 764
J&J to engage with customers at TSE. Company overview Aug 19, 2013 654
UrgentRx offers relief wherever needed. Company overview Aug 19, 2013 640
Genomma raises profile in U.S. market. Company overview Aug 19, 2013 640
Homeolab stresses product differentiation. Company overview Aug 19, 2013 665
The relevance and importance of business development and licensing in the biopharmaceutical industry. Davies, Roger Jul 1, 2013 3878
McKesson takes pressure off Rx. Jun 3, 2013 432
Front-end business assumes greater importance. Jun 3, 2013 500
Indian firms in Africa point the way. May 1, 2013 446
Pharmaceutical companies, faced with growing pricing pressures, should look outside their products for new revenue opportunities. Burrill, G. Steven Report Apr 1, 2013 1506
The industry-focused international strategy prevalence and profile. Mascarenhas, Briance Report Mar 1, 2013 7009
Bergstrom Nutrition. Brief article Mar 1, 2013 215
Elizabeth. Company overview Mar 1, 2013 517
A bad rap? Nashua compound pharmacist worries about image of his industry after outbreak. Nov 2, 2012 358
Hauppauge, N.Y. Company overview Oct 29, 2012 599
Mexico City. Company overview Oct 29, 2012 576
Facing cross-industry challenges in the food and pharma industries: both industries may benefit from adopting best practices. Boogaard, Peter J. Oct 1, 2012 1854
Hi-Tech Pharmacal. Sep 24, 2012 608
Wockhardt USA. Sep 24, 2012 595
Innovative biotechnology industry strategies in the U.S.' rapidly evolving payer environment. Collins, Sarah Stanton; Collins, Will Report Jul 1, 2012 5146
Concepts In Health broadens its scope. Interview Jun 25, 2012 840
Do investors care about earnings management? Latif, Saira; Yang, Yi Report Jun 22, 2012 5239
Federal science and technology in brief. Jun 22, 2012 433
Genomma steadily expands presence in U.S. market. Company overview Jun 18, 2012 719
ValveXchanae. Brief article Apr 1, 2012 186
Category driven by innovation. Brief article Mar 26, 2012 194
Having the human touch. Column Mar 1, 2012 794
New Annex 11: evolution and consequences. Jan 1, 2012 1852
Informatics engine drives: Pharma development toward quality by design: learning from other industries. Boogaard, Peter J.; Griep, Hans Dec 1, 2011 2496
Management bumps up earnings projection. Nov 21, 2011 422
DRUGS PROBLEM : ANNUAL EU DRUGS REPORT POINTS TO NEW THREATS. Nov 16, 2011 486
Patent strategies for life sciences companies to navigate the changing patent landscape. Abramson, Danielle T.; Dykeman, David J. Nov 1, 2011 3506
Some pearls of Wisdom from Turkish friends. Oct 31, 2011 562
Pharma-sponsored comparison studies hold clinical value. Pfeiffer, Amy Oct 15, 2011 800
Compliance issue analyzed. Aug 29, 2011 476
PROfile program helps tighten ties with patients. Brief article Aug 29, 2011 195
Enforcement efforts and partnership with industry: a needed strategy addressing counterfeit drugs. Kubic, Thomas T. Aug 1, 2011 2544
Chiesi group - Italy. Company overview Jun 1, 2011 1374
Sante private limited. Company overview Jun 1, 2011 774
Development and reliability assessment of trilogy scale with practicability, competence & importance of patient oriented services. Sarriff, Azmi; Gillani, Wasif S.; Babiker, Ghada Abdel Raheem M. Report Jun 1, 2011 11997
The digital juggle: meeting the information demands of business executives, regulators and counsel in the pharmaceutical industry. Rashbaum, Kenneth N. Apr 1, 2011 701
GSK creates support team for retail pharmacists. Mar 28, 2011 456
A conundrum. Lawrence, Corrine Editorial Mar 1, 2011 358
Challenges and trends. Mar 1, 2011 358
Closed vial technology: a new solution to improve sterility assurance levels and to simplify the aseptic filling process. Verjans, Benoit Mar 1, 2011 996
Black to the future plants with agility; A two-floor facility that incorporates the 'black to white' concept may provide oral solid dosage manufacturers with an effective solution for future demands. Spook, Wim J. Mar 1, 2011 1727
A South African herb that may rival Prozac: remember the anti-weight-gain herb Hoodia used by the San people of South Africa? Now, an even more exciting discovery could take the world of antidepressants by storm. The herb, found in the same regions as Hoodia, seems to be nature's answer to depression and anxiety. The global market is enormous but so are the legal and regulatory hurdles. Dr Sean Carey* reports. Carey, Sean Industry overview Mar 1, 2011 1842
Consumer Product Testing Co. Inc. Company overview Mar 1, 2011 450
TSI Health Sciences, Inc. Company overview Mar 1, 2011 327
ZMC-USA. Company overview Mar 1, 2011 438
Branded drug manufacturers look to hone competitive edge. Feb 28, 2011 661
Generic drugs have a friend in 'the formulary'. Coopman, Robert Feb 28, 2011 640
As health reform advances, NCPDP highlights milestones. Feb 28, 2011 570
Revitalizing portfolio decision-making at Merck Serono S.A.--Geneva. Aurentz, Vincent; Kirschbaum, Bernhard; Thunecke, Markus Report Feb 1, 2011 5792
Hi-Tech Pharmaceuticals. Company overview Jan 17, 2011 446
Outsourcing roundable review. Report Jan 1, 2011 4416
Field notes from the cancer wars: the war against nutrients and natural products - Part 2. Cohen, Marcus A. Dec 1, 2010 2426
Industry-physician ties persist. Anderson, Jane Brief article Dec 1, 2010 182
Clinical trial insurance in South Korea. Doherty, Jon Nov 1, 2010 650
Battle against diabetes remains a high priority. Oct 25, 2010 380
Tool kit tackles issue of medication abuse. Brief article Oct 25, 2010 256
Products return to marketplace. Brief article Sep 27, 2010 195
Greenstone on lookout for alliances. Company overview Sep 27, 2010 370
Lupin Pharmaceuticals Inc. Sep 27, 2010 451
Amneal Pharmaceuticals LLC. Sep 27, 2010 1089
Heritage Pharmaceuticals Inc. Sep 27, 2010 429
Kremers-Urban LLC. Sep 27, 2010 342
CorePharma LLC. Sep 27, 2010 305
Actavis. Sep 27, 2010 422
Wockhardt USA LLC. Sep 27, 2010 351
Gavis Pharmaceuticals LLC. Sep 27, 2010 578
Hi-Tech Pharmacal. Sep 27, 2010 576
Teva Pharmaceuticals. Company overview Sep 27, 2010 549
Zydus Pharmaceuticals (USA) Inc. Company overview Sep 27, 2010 599
Glenmark Generics Inc. USA. Company overview Sep 27, 2010 677
Dr. Reddy's. Company overview Sep 27, 2010 493
Roxane Laboratories Inc. Company overview Sep 27, 2010 432
Camber Pharmaceuticals Inc. Company overview Sep 27, 2010 431
Covidien Pharmaceuticals. Company overview Sep 27, 2010 387
Prasco Laboratories. Company overview Sep 27, 2010 679
Bedford Laboratories. Company overview Sep 27, 2010 435
A model for quantifying strategic supplier selection: evidence from a generic pharmaceutical firm supply chain. Enyinda, Chris I.; Dunu, Emeka; Bell-Hanyes, Janel Sep 22, 2010 8120
Purchasing alliance for generics set. Brief article Sep 13, 2010 175
AARP study finds branded drug prices at retail are rising. Sep 13, 2010 422
GSK campaign touts Nicorette. Brief article Sep 13, 2010 118
PLMA report looks beyond the recession. Sep 13, 2010 345
Beiersdorf, Unilever step up promos with latest launches. Sep 13, 2010 778
Research-driven industry intent on solving health problems. Company rankings Aug 30, 2010 1532
R&D projects target mental illness. Brief article Aug 30, 2010 284
Suppliers participate in reform process. Aug 30, 2010 372
Health care reform bill a boon for biotech sector. Aug 30, 2010 453
Generics keep costs down. Company rankings Aug 30, 2010 868
J&J discloses more subpoenas over consumer recalls. Johnson & Johnson. Brief article Aug 16, 2010 291
Remember the good old days? Bourque, Ron Column Aug 13, 2010 728
CEO sees innovation crisis. Jul 19, 2010 568
Demonizing the insurance companies while giving the drug companies a pass. Gaby, Alan R. Editorial Jul 1, 2010 836
Creative financing: the SEDA, a financial "bridge" for biotechs. Nowak, Mike Report Jul 1, 2010 1746
Leon Koffler, chairman--Super-Pharm Israel Ltd. Jun 14, 2010 370
Web site lets Good Neighbor stores level playing field. Jun 7, 2010 373
WellSpring always puts consumers first. Company overview Jun 7, 2010 610
Beiersdorf drives innovation in skin care. Jun 7, 2010 638
Inviragen Inc. Brief article Jun 1, 2010 202
Specialist provider of powder-based solutions. Brief article May 1, 2010 255
What the experts say: pharma talks to industry experts about the trends, challenges and the future of the industry. Interview May 1, 2010 2016
The laboratory: your key to commercial success. Smewing, Jo May 1, 2010 431
Have your business risks gone global? Roche, Tom May 1, 2010 1956
Error-free handling: logistics' Holy Grail; driven by market demands, the error-free warehouse is within reach, according to Craig Rollason, Head of Sales & Marketing for KNAPP UK Ltd. In this article, he describes the technologies bringing the Holy Grail of materials handling ever closer. Rollason, Craig May 1, 2010 953
Health Mart model attracts growing roster of members. Company overview Apr 26, 2010 556
Sav-Mor rises to challenge. Company overview Apr 26, 2010 514
Oncology medication program O.K.'d. Brief article Mar 15, 2010 213
ActiTech. Company overview Mar 1, 2010 280
Amax NutraSource, Inc. Company overview Mar 1, 2010 306
Capsugel. Brief article Mar 1, 2010 238
Indena. Company overview Mar 1, 2010 440
Jiaherb Inc. Company overview Mar 1, 2010 304
Dispensary management: systems security, consistency and control. Mar 1, 2010 1285
FTC on pay-for-delay deals. Feb 15, 2010 573
Outlook for generics is still bullish. Feb 15, 2010 484
Generics get a push from pharmacies. Feb 15, 2010 410
Biogenerics fight is sure to go on. Brief article Feb 15, 2010 116
Reform's fate could impact stock prices. Feb 15, 2010 399
'Pay for delay' has role to play in success of generics. Coopman, Robert Feb 15, 2010 732
A 27-year-old hay fever treatment being studied by Pfizer Inc (New York) and Medivation Inc (San Francisco CA) for Alzheimer's disease may also help patients with Huntington's disease. Feb 15, 2010 348
Drug developer Shire Plc (Basingstoke UK) said its potential Gaucher disease drug showed positive results in a late-stage study. Financial report Feb 15, 2010 340
Pfizer Inc (New York) Chief Executive Officer Jeffrey Kindler said much of his three-year tenure has been focused on correcting past management mistakes, including the failure of an inhaled insulin product that cost the company at least $2.8 billion. Brief article Jan 11, 2010 238
GSK puts Advantage Brands plan in action. Jan 4, 2010 417
Reinventing the pharmaceutical industry, without the industry: the founder of the Pink Army Cooperative is bringing the open-source development model to breast cancer therapies. Hessel, Andrew Jan 1, 2010 1145
An exit strategy for the downturn: Catherine Jablonsky, business development director, pharmaceutical business unit, AspenTech, discusses how pharmaceutical companies are forging a way forward through process efficiencies. Jablonsky, Catherine Jan 1, 2010 1041
No risk management or poor risk management? Nostrapharmus calls for good risk management practice to satisfy both regulatory demands and business needs. Jan 1, 2010 1155
Conley draws on lab experience for McKesson. DiRamio, Denise Guest editorial Jan 1, 2010 569
Search for new strategies. Nov 23, 2009 488
IPO sector: Omeros Corp. (Seattle WA) sold $68.2 million worth of common stock in its Wall Street debut. Brief article Oct 19, 2009 166
McKesson serves up solutions. Company overview Oct 12, 2009 606
Effective communication is key. Brief article Oct 12, 2009 160
Health Mart hones best practices. Oct 12, 2009 467
Community Rx always top of mind at AmerisourceBergen. Company overview Oct 12, 2009 603
H.D. Smith helps clients grow. Company overview Oct 12, 2009 458
Teva Pharmaceuticals. Company overview Sep 28, 2009 570
Mylan Inc. Company overview Sep 28, 2009 666
Wockhardt USA LLC. Company overview Sep 28, 2009 397
Cypress Pharmaceutical Inc. Company overview Sep 28, 2009 350
Lupin Pharmaceuticals Inc. Company overview Sep 28, 2009 380
Mallinckrodt Pharmaceuticals. Company overview Sep 28, 2009 387
FDA: Rx makers on track. Sep 28, 2009 428
Securing the supply chain. Sep 28, 2009 518
Amneal Pharmaceuticals LLC. Company overview Sep 28, 2009 1029
Hi-Tech Pharmacal Co. Company overview Sep 28, 2009 714
Dr. Reddy's Laboratories Inc. Company overview Sep 28, 2009 483
Greenstone LLC. Company overview Sep 28, 2009 409
Breckenridge Pharmaceutical Inc. Company overview Sep 28, 2009 423
Sandoz Inc. Company overview Sep 28, 2009 341
Ranbaxy Laboratories Ltd. Company rankings Sep 28, 2009 894
Lannett Co. Company overview Sep 28, 2009 400
Heritage Pharmaceuticals Inc. Company overview Sep 28, 2009 595
Glenmark Generics Inc. USA. Company overview Sep 28, 2009 602
Boca Pharmacal Inc. Company overview Sep 28, 2009 378
Camber Pharmaceuticals Inc. Company overview Sep 28, 2009 451
Kremers-Urban LLC. Company overview Sep 28, 2009 389
Has the regulation of physician-industry relationships gone too far? Regulation is necessary. Carlat, Daniel Viewpoint essay Sep 1, 2009 509
Pharmachem Laboratories: a decade of expansion. Company overview Sep 1, 2009 723
UAS Laboratories: prizing the power of probiotics. Company overview Sep 1, 2009 826
Dispensing wisdom: sophisticated product formulations lead to packaging and dispensing challenges, says Mark Box, Managing Director of Rieke dispensing. Box, Mark Sep 1, 2009 587
Brecon's unique outsourcing proposition. Sep 1, 2009 328
Specialist CMO launches commercial supply service. Sep 1, 2009 334
A brave new world of pharmaceutical sales. Sep 1, 2009 716
'Rx research has never held more promise'. Aug 3, 2009 663
Harry and Louise make return with a different message. Aug 3, 2009 383
Study eyes biopharmaceutical sector. Brief article Aug 3, 2009 270
Opportunities off the beaten track in the knowledge outsourcing field: a knowledge process outsourcing sector doing well even in these challenging times is in the healthcare and pharmaceutical knowledge space. Some argue that the scale is too small to consider growth but not being overloaded has helped such companies to do well. Dutt, Ashish Aug 1, 2009 1146
Blake to run McKesson Technology Solutions. Company overview Jul 20, 2009 603
Teva roundtable eyes affordable care. Brief article Jul 20, 2009 119
One healthy company creates another. Brief article Jul 1, 2009 236
I Holland Ltd. Company overview Jul 1, 2009 472
Indena. Company overview Jul 1, 2009 553
Lonza Ltd. Company overview Jul 1, 2009 405
Cognis GmbH. Company overview Jul 1, 2009 271
Health claims rejected by EFSA: Naturalpha's opinion: EFSA has issued a negative opinion for almost 80% of the health claims submitted by agro-food companies. Naturalpha proposes a better understanding of EFSA's expectations, based on its scientific and regulatory expertise. Gazo, Emilie Jul 1, 2009 932
Cincinnati calling opportunities abound in the buckeye state. Company overview Jul 1, 2009 2417
Purdue always caters to core customers. Company overview Jun 29, 2009 472
Stiefel works to advance dermatology. Company overview Jun 29, 2009 398
CutisPharma facilitates Rx compounding. Company overview Jun 29, 2009 1214
University Medical emphasizes efficacy. Company overview Jun 29, 2009 419
NextWave eschews me-too products. Company overview Jun 29, 2009 388
Merz makes a splash with TV campaign. Company overview Jun 29, 2009 547
Alva-Amco helps drive incremental sales. Company overview Jun 29, 2009 828
Diverse strengths fuel Paddock growth. Brief article Jun 29, 2009 274
Nivea leads charge for Beiersdorf in '09. Company overview Jun 29, 2009 824
Incredible Scents aims to quiet snorers. Company overview Jun 29, 2009 600
Vaccinations facilitated by VaxAmerica. Company overview Jun 29, 2009 475
Improve your containment. Brief article May 1, 2009 336
Hydroxypropyl betacyclodextrin. Dusautois, Cecile May 1, 2009 3101
Vacuum pumps for pharmaceutical processes: Dr Don Collins, Market Development Manager, Chemical Sector, Edwards, discusses vacuum pumping technologies and how pharmaceutical manufacturing managers can optimize their vacuum processes. Collins, Don May 1, 2009 1797
New problems, new CRM solutions. Giardina, Annette May 1, 2009 1065
Sav-Mor takes steps to stimulate demand. Company overview Apr 20, 2009 438
E-mail can build ties with patients. Brief article Apr 20, 2009 113
Priorities are realigned by Dr. Reddy's. Brief article Apr 20, 2009 204
The way of the regulator: applying pharmaceutical principles now could pave the way to a risk-free future. Robinson, Kevin Editorial Mar 1, 2009 814
ActiTech. Company overview Mar 1, 2009 281

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |